Assignee
BARUCH S BLUMBERG INST
US·8 granted patents·10 pending applications·0 citations·filing 2013–2023
Top patents by PatentIndex Score
18 records- 0169US2021041458A1Lectin Assay For Assessing Glycoforms As An Early Marker In DiseaseBARUCH S BLUMBERG INST·Filed 2020·Application pending·0 cites
- 0260US2025197360A1Novel diazepines that target yellow fever virus non-structural 4b (ns4b) protein and their method of useBARUCH S BLUMBERG INST·Filed 2023·Application pending·0 cites
- 0359US2016327571A1Lectin Assay For Assessing Glycoforms As An Early Marker In DiseaseBARUCH S BLUMBERG INST·Filed 2016·Application pending·0 cites
- 0458US9168260B2Benzodiazepine compounds with anti-flavivirus activityBARUCH S BLUMBERG INST·Filed 2013·Granted Oct 27, 2015·0 cites·1 claims
- 0557US9126937B2Alkylated imino sugars exhibiting glucosidase inhibition and their method of useBARUCH S BLUMBERG INST·Filed 2013·Granted Sep 8, 2015·0 cites·7 claims
- 0655US2025296929A1Novel hepatoselective polyadenylating polymerases inhibitors and their method of useBARUCH S BLUMBERG INST·Filed 2022·Application pending·0 cites
- 0754US2024207248A1Methods, kits and compositions for reducing chromosomal instability in cancer cellsBARUCH S BLUMBERG INST·Filed 2022·Application pending·0 cites
- 0851US10376502B2Alkylated imino sugars exhibiting glucosidase inhibition and their method of useBARUCH S BLUMBERG INST·Filed 2015·Granted Aug 13, 2019·0 cites·5 claims
- 0950US10087173B2Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replicationBARUCH S BLUMBERG INST·Filed 2016·Granted Oct 2, 2018·0 cites·5 claims
- 1050US2015307443A1Functionalized benzamide derivatives as antiviral agents against hbv infectionBARUCH S BLUMBERG INST·Filed 2013·Application pending·0 cites
- 1150US2019092720A1Functionalized benzamide derivatives as antiviral agents against hbv infectionBARUCH S BLUMBERG INST·Filed 2018·Application pending·0 cites
- 1249US2024000977A1Methods and kits for diagnosing and treating cancersBARUCH S BLUMBERG INST·Filed 2021·Application pending·0 cites
- 1349US2021371388A1Bicyclic Carboxamide with Exocyclic Urea Derivatives as Antivirals for the Treatment of HBV InfectionBARUCH S BLUMBERG INST·Filed 2021·Application pending·0 cites
- 1448US12509436B2Benzamide derivatives as cGAS-sting pathway agonistsBARUCH S BLUMBERG INST·Filed 2019·Granted Dec 30, 2025·0 cites·10 claims
- 1541US2023035491A1Methods, kits and compositions for reducing cardiotoxicity associated with cancer therapiesBARUCH S BLUMBERG INST·Filed 2020·Application pending·0 cites
- 1640US9657013B2Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of useBARUCH S BLUMBERG INST·Filed 2013·Granted May 23, 2017·0 cites·33 claims
- 1738US10421723B22,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of useBARUCH S BLUMBERG INST·Filed 2017·Granted Sep 24, 2019·0 cites·20 claims
- 1834US10913734B2Substituted aminothiazolesBARUCH S BLUMBERG INST·Filed 2017·Granted Feb 9, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when BARUCH S BLUMBERG INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →